about
Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline.Neuroimaging tools to rate regional atrophy, subcortical cerebrovascular disease, and regional cerebral blood flow and metabolism: consensus paper of the EADC.Multi-center comparison of medial temporal atrophy in patients with Alzheimer's disease--data from the ICTUS study.Aging.Medial temporal atrophy in early and late-onset Alzheimer's disease.Norms for imaging markers of brain reserve.Volume of interest-based [18F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study.Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progressionTemporal lobe asymmetry in patients with Alzheimer's disease with delusionsThe effect of white matter lesions on cognition in the elderly--small but detectable.White matter lesions in the elderly: pathophysiological hypothesis on the effect on brain plasticity and reserve.Mapping the effect of APOE epsilon4 on gray matter loss in Alzheimer's disease in vivoWhite matter damage in Alzheimer disease and its relationship to gray matter atrophy.Predictors of cognitive decline and treatment response in a clinical trial on suspected prodromal Alzheimer's disease.Preliminary evidence of validity of the revised criteria for Alzheimer disease diagnosis: report of 2 cases.Effects of rivastigmine on visual attention in subjects with amnestic mild cognitive impairment: A serial functional MRI activation pilot-study.Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a 'European ADNI study'.Multisite longitudinal reliability of tract-based spatial statistics in diffusion tensor imaging of healthy elderly subjects.Regional atrophy of transcallosal prefrontal connections in cognitively normal APOE epsilon4 carriers.Cerebrospinal fluid markers for Alzheimer's disease in a cognitively healthy cohort of young and old adults.Supporting evidence for using biomarkers in the diagnosis of MCI due to AD.APOE4 is associated with greater atrophy of the hippocampal formation in Alzheimer's disease.Distinctive clinical features of mild cognitive impairment with subcortical cerebrovascular disease.Distinct cerebrospinal fluid amyloid-beta peptide signatures in cognitive decline associated with Alzheimer's disease and schizophrenia.Markers of Alzheimer's disease in a population attending a memory clinic.Hippocampal and amygdalar volume changes in elderly patients with Alzheimer's disease and schizophrenia.Prescription practices of diagnostic imaging in dementia: a survey of 47 Alzheimer's Centres in Northern Italy.Vascular damage and EEG markers in subjects with mild cognitive impairment.Validation study of a CT-based weighted rating scale for subcortical ischemic vascular disease in patients with mild cognitive deterioration.The MRI pattern of frontal and temporal brain atrophy in fronto-temporal dementia.Development of a CT-based weighted rating scale for subcortical cerebrovascular disease sensitive to mild clinical symptoms.Visual versus semi-quantitative analysis of 18F-FDG-PET in amnestic MCI: an European Alzheimer's Disease Consortium (EADC) project.Cardiac autonomic dysfunction is associated with white matter lesions in patients with mild cognitive impairment.The use of biomarkers for the etiologic diagnosis of MCI in Europe: an EADC survey.Topographic correspondence between white matter hyperintensities and brain atrophy.The new Alzheimer's criteria in a naturalistic series of patients with mild cognitive impairment.Validation study of the three-objects-three-places test: a screening test for Alzheimer's disease.Hippocampal shape differences in dementia with Lewy bodies.Mild cognitive impairment with subcortical vascular features: clinical characteristics and outcome.Autonomic dysfunction in mild cognitive impairment: a transcranial Doppler study
P50
Q30996727-06A1233B-F7C1-48A8-93FF-F36525774634Q33194112-76F7343D-477E-45BE-B092-A73E5B1E0164Q33374508-849BF15B-BB1C-40C5-98F0-88ECD7AE03DBQ33378546-B4CB7E1F-92F9-4E53-87E6-3BDDF92CC98BQ33742027-3EA460AA-4A35-4C98-A69D-EE71CE13D8A3Q34294709-E93964F6-9BCC-4CE4-B1A9-917798E20F4FQ34988405-EF9FCD40-D448-4B1F-918F-13392B9A46BDQ35106472-CC299CFA-6B97-45B1-B962-D856F097E28AQ35458508-91DFB694-9695-4E6D-8A99-94EFA2E82E2DQ36992957-ACAF5C5C-D493-4950-AFEC-A57A33D78B22Q37232382-015331E5-29FC-4BB4-A2B7-53BB600AC415Q37337930-29507FC9-9167-4D61-A660-A5E34134E23EQ37823007-41E45E1A-803D-4899-9852-12621BB18C82Q38395932-ACB79452-7A58-4A25-8923-2779075FFF87Q39966471-D4D81B26-FAF1-42B8-BBA7-2316605A8059Q40017838-794C3C56-C797-473C-8900-55925D48C112Q40873275-BDF0004F-5433-414F-8202-99509992A284Q44459495-DC2FCC43-FD29-4EC6-A8CE-A62DB84F54ECQ44887852-E55E4C65-EAF5-43A5-8209-ECBA61769CDFQ45122098-1A8DB826-BA6E-4293-AC3E-805C156F44CAQ45178246-5EBCF61F-211E-49B1-A527-92CB6E9CB470Q45222661-1BECFE87-837E-4850-8A56-763F9D9DC467Q45225244-8F33B5D1-C938-474E-9D45-0452F5A1FB72Q45420612-6BC87713-22C8-4130-81FF-64230AF95767Q45950049-353EDE5E-0D3A-4C01-8F29-F3E155E3F0FAQ46608068-434BB5B5-2C33-4F36-9875-3A6BBFA6C035Q47794675-2902B057-4422-42A7-B2EE-093D358D725BQ48132770-5E7F8D89-608C-40B8-A6DB-B639A35A677FQ48315853-A81B378E-BE76-4469-80F0-366C845A99A0Q48422206-2C221961-F050-4B8D-8E88-420F7D593198Q48453687-855020DD-F1C0-4567-997C-A8CCE49EDD74Q48468901-5A03A2A9-B69A-4159-BC1D-A9D325E28270Q48498399-F2C14FB9-E0AA-4EBD-AF3F-9C177748CAABQ48588765-84BE2CEE-96E9-44F9-956A-1BD6ADF2E891Q48636682-F643CB84-5EE8-4E19-AA02-74DBBC7EA9BEQ51045198-D5E2ABFA-92B6-470A-84F6-B93D2B392D60Q51721044-7BD94B86-0419-428A-BA26-505FC63A9AF9Q51886737-27F660F2-E3F3-4504-A68D-8295C0610FF8Q51952790-BD651B38-3308-488D-91E3-52B73F0F0E8FQ57628352-154A2617-E58C-4C22-B7CB-503BAB66C5D6
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Samantha Galluzzi
@ast
Samantha Galluzzi
@en
Samantha Galluzzi
@es
Samantha Galluzzi
@nl
Samantha Galluzzi
@sl
type
label
Samantha Galluzzi
@ast
Samantha Galluzzi
@en
Samantha Galluzzi
@es
Samantha Galluzzi
@nl
Samantha Galluzzi
@sl
prefLabel
Samantha Galluzzi
@ast
Samantha Galluzzi
@en
Samantha Galluzzi
@es
Samantha Galluzzi
@nl
Samantha Galluzzi
@sl
P1053
K-5218-2016
P106
P1153
6602161538
P21
P31
P3829
P496
0000-0001-9804-5669